These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 571582)

  • 1. [Action of trazodone on the secretion of pituitary hormones. Behavior of prolactin and somatotropin].
    Mazzi C; Montanini R; Riva LP
    Minerva Med; 1979 Mar; 70(13):935-40. PubMed ID: 571582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bromocryptin in obstetrics and gynecology].
    Alipov VI; Beskrovnaia NI
    Akush Ginekol (Mosk); 1980 Jul; (7):3-6. PubMed ID: 6998309
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases].
    Mel'nichenko GA; Bol'shakova TD; Gitel' EP; Langner TK; Barkova MV
    Probl Endokrinol (Mosk); 1983; 29(1):19-23. PubMed ID: 6682222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of bromocriptine to induce ovulation in the galactorrhea-amenorrhea syndrome [].
    Hernández Ayup S; Muñoz M; González R; Galache P; Guitrón A; Pancardo RM; Forsbach G
    Rev Invest Clin; 1982; 34(2):121-3. PubMed ID: 7123023
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bromoergocryptine (CB 154) and pregnancy. Notes on 2 cases].
    Pagliani A; Modena G
    Minerva Ginecol; 1979 Jun; 31(6):461-5. PubMed ID: 492588
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of CB-154 (2-Br-alpha-ergocryptine) on prolactin and growth hormone release in an acromegalic patient with galactorrhea.
    Ueda G; Sato Y; Yamasaki M; Shioji T; Aono T
    Endocrinol Jpn; 1975 Jun; 22(3):265-8. PubMed ID: 1242128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal pregnancies after treatment of hyperprolactinemia with bromoergocryptine, despite suspected pituitary tumors.
    Mornex R; Orgiazzi J; Hugues B; Gagnaire JC; Claustrat B
    J Clin Endocrinol Metab; 1978 Aug; 47(2):290-5. PubMed ID: 400717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of clomiphene for treating lactorrhea and amenorrhea].
    Pishchulin AA; Mel'nichenko GA
    Probl Endokrinol (Mosk); 1982; 28(2):31-4. PubMed ID: 7043448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue culture studies on human pituitary tumours: long term release of anterior pituitary hormones into the culture medium.
    Lipson LG; Beitins IZ; Kornblith PL; McArthur JW; Friesen HG; Kliman B; Kjellberg RN
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):421-33. PubMed ID: 218413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy following bromocryptine therapy for the amenorrhoea-galactorrhoea syndrome due to a pituitary tumour.
    Perry-Keene DA; Warne GL; Martin FI
    Med J Aust; 1976 Oct; 2(16):602-4. PubMed ID: 1036755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.
    Jeske W
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):385-96. PubMed ID: 112817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of blockers and stimulators of prolactin secretion in persistent lactorrhea-amenorrhea syndrome.
    Starkova NT; Mel'nichenko GA
    Neurosci Behav Physiol; 1980; 10(6):476-80. PubMed ID: 6783976
    [No Abstract]   [Full Text] [Related]  

  • 18. [The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
    Nicoletti I; Filipponi P; Nunzi E; Angeletti G; Santeusanio F
    Minerva Med; 1980 Jan; 71(2):89-96. PubMed ID: 7188809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyridoxine treatment of galactorrhoea-amenorrhoea syndromes.
    Lehtovirta P; Ranta T; Seppälä M
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):682-6. PubMed ID: 580517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.